Coverage
-
November 22, 2017
An Ohio federal judge on Wednesday refused to grant a new trial to parents of a child born with birth defects who claimed that Abbott Laboratories Inc. didn't warn patients of the risks of its anticonvulsant drug Depakote, finding the jury wasn't given erroneous instructions.
2 other articles on this case.
View all »